The coronary artery bypass graft market size has grown strongly in recent years. It will grow from $11.45 billion in 2023 to $12.5 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The expansion observed in the historical period can be attributed to factors such as an aging population, the growth of healthcare infrastructure, an increase in cardiovascular diseases, awareness campaigns, and expanded insurance coverage.
The coronary artery bypass graft market size is expected to see strong growth in the next few years. It will grow to $17.37 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The anticipated growth in the forecast period can be attributed to the expansion of ambulatory surgery centers (ASCs), the integration of digital health, the growth of telemedicine, the utilization of remote patient monitoring devices, and the adoption of patient-centric approaches. Major trends in the forecast period include advancements in surgical techniques, collaborative research, the incorporation of robotics in surgery, the development of biodegradable implants, the use of AI for diagnostic purposes, and the implementation of virtual reality training for surgeons.
The anticipated rise in the prevalence of cardiovascular diseases is poised to propel the expansion of the coronary artery bypass graft market in the future. Cardiovascular disease (CVD) encompasses various heart and blood vessel ailments. To reduce the risk of heart attacks, a coronary artery bypass graft (CABG) creates a new pathway for blood flow around blocked or partially blocked arteries in the heart. As per a journal published by Oxford University Press, a UK-based university press, the percentage of people affected by peripheral artery diseases is expected to increase by 50% by 2045. Consequently, the increased prevalence of cardiovascular diseases drives the growth of the coronary artery bypass graft market.
The growing geriatric population is anticipated to be a driving force behind the expansion of the coronary artery bypass graft market. The geriatric population consists of individuals who are elderly or of advanced age. Coronary artery bypass graft (CABG) surgery addresses severe coronary artery disease (CAD) in the geriatric population by bypassing blocked or narrowed arteries with healthy blood vessels. This restores blood flow to the heart muscle and improves its function. According to the World Health Organization, globally, one in six people will be 60 or older by 2030, and the number of individuals in this age group is expected to double to 2.1 billion by 2050. Additionally, a report by the UK Parliament's House of Commons Library indicates that by 2043, seniors will make up 24% of the total population in the UK, reaching 17.4 million people. Therefore, the increasing geriatric population is fostering the growth of the coronary artery bypass graft market.
Strategic collaboration emerges as a prominent trend gaining traction in the coronary artery bypass graft market, with major companies focusing on partnerships to fortify their positions and gain a competitive edge. For example, Medtronic plc, a US-based medical device company, collaborated with CathWorks, an Israel-based medical equipment manufacturer. The collaboration involves Medtronic investing a maximum of $75 million in CathWorks and jointly promoting CathWorks' FFRangio System in the United States, Japan, and Europe. Another instance is the collaboration between Etiometry, a US-based clinical decision-support software provider, and Terumo Cardiovascular, a US-based manufacturer of medical devices for cardiac and vascular surgery. This collaboration aims to provide advanced clinical decision support for adult cardiac surgery patients during and after their post-surgical recovery.
Major companies operating in the coronary artery bypass graft market are innovating and introducing new products, including a suite of medical devices, to gain a competitive advantage. For instance, CardioPrecision Ltd, a UK-based medical technology company, launched a suite of CoreVista devices designed for use in endoscopic vessel harvesting (EVH) during coronary artery bypass grafting (CABG) surgery. These devices aim to revolutionize EVH by offering a less invasive alternative to traditional open vessel harvesting, optimizing the environment for training and independent clinical practice.
In August 2022, Medtronic plc, a US-based medical device company, completed the acquisition of Affera Inc. for an undisclosed amount. This acquisition enhances Medtronic's cardiac ablation lineup by introducing a cardiac mapping and navigation platform, incorporating a distinctive diagnostic tool, focused pulsed field technology, and a radiofrequency ablation solution. Affera Inc. is a US-based medical technology company specializing in coronary artery bypass graft (CABG) procedures.
Major companies operating in the coronary artery bypass graft market report are MicroPort Scientific Corporation, CryoLife Inc., Johnson & Johnson Co, Abbott Laboratories, Medtronic plc, Stryker Corporation, Northwell Health, Boston Scientific Corporation, Penn Medicine, Geisinger Health System Co, Terumo Corporation, Edwards Lifesciences Corporation, Main Line Health Inc., Getinge AB, Teleflex Incorporated, W. L. Gore & Associates Inc., Guidant Group, LivaNova PLC, AtriCure Inc., Peter Surgical, Sorin Group, Cardiva Medical Inc., Genesee Biomedical Inc., Dextera Surgical Inc., Cardica Inc., Maquet Holding B.V. & Co.KG, Novadaq Technologies Inc., Karl Storz GmbH & Co. KG, Vitalitec International Medizintechnik GmbH, Hancock Jaffe Laboratories.
North America was the largest region in the coronary artery bypass graft market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary artery bypass graft market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coronary artery bypass graft market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The primary procedures for coronary artery bypass grafting include single coronary artery bypass graft (CABG) surgery, double coronary artery bypass graft (CABG) surgery, triple coronary artery bypass graft (CABG) surgery, quadruple coronary artery bypass graft (CABG) surgery, and others. Single coronary artery bypass graft (CABG) surgery is a surgical intervention utilized for the management of coronary heart disease. Both off-pump and on-pump methods are employed by various healthcare facilities, including hospitals, cardiology clinics, research institutes, and other end-users.
The coronary artery bypass graft research report is one of a series of new reports that provides coronary artery bypass graft market statistics, including the coronary artery bypass graft industry's global market size, regional shares, competitors with coronary artery bypass graft market share, detailed coronary artery bypass graft market segments, market trends and opportunities, and any further data you may need to thrive in the coronary artery bypass graft industry. This coronary artery bypass graft market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The coronary artery bypass graft market consists of revenues earned by entities by providing services such as bypass grafts, peripheral vascular grafts, hemodialysis access grafts, and endovascular stent grafts. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary artery bypass graft market also includes sales of forceps, vascular forceps, grasping forceps, needle holders, scissors, and clamps. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The coronary artery bypass graft market size is expected to see strong growth in the next few years. It will grow to $17.37 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The anticipated growth in the forecast period can be attributed to the expansion of ambulatory surgery centers (ASCs), the integration of digital health, the growth of telemedicine, the utilization of remote patient monitoring devices, and the adoption of patient-centric approaches. Major trends in the forecast period include advancements in surgical techniques, collaborative research, the incorporation of robotics in surgery, the development of biodegradable implants, the use of AI for diagnostic purposes, and the implementation of virtual reality training for surgeons.
The anticipated rise in the prevalence of cardiovascular diseases is poised to propel the expansion of the coronary artery bypass graft market in the future. Cardiovascular disease (CVD) encompasses various heart and blood vessel ailments. To reduce the risk of heart attacks, a coronary artery bypass graft (CABG) creates a new pathway for blood flow around blocked or partially blocked arteries in the heart. As per a journal published by Oxford University Press, a UK-based university press, the percentage of people affected by peripheral artery diseases is expected to increase by 50% by 2045. Consequently, the increased prevalence of cardiovascular diseases drives the growth of the coronary artery bypass graft market.
The growing geriatric population is anticipated to be a driving force behind the expansion of the coronary artery bypass graft market. The geriatric population consists of individuals who are elderly or of advanced age. Coronary artery bypass graft (CABG) surgery addresses severe coronary artery disease (CAD) in the geriatric population by bypassing blocked or narrowed arteries with healthy blood vessels. This restores blood flow to the heart muscle and improves its function. According to the World Health Organization, globally, one in six people will be 60 or older by 2030, and the number of individuals in this age group is expected to double to 2.1 billion by 2050. Additionally, a report by the UK Parliament's House of Commons Library indicates that by 2043, seniors will make up 24% of the total population in the UK, reaching 17.4 million people. Therefore, the increasing geriatric population is fostering the growth of the coronary artery bypass graft market.
Strategic collaboration emerges as a prominent trend gaining traction in the coronary artery bypass graft market, with major companies focusing on partnerships to fortify their positions and gain a competitive edge. For example, Medtronic plc, a US-based medical device company, collaborated with CathWorks, an Israel-based medical equipment manufacturer. The collaboration involves Medtronic investing a maximum of $75 million in CathWorks and jointly promoting CathWorks' FFRangio System in the United States, Japan, and Europe. Another instance is the collaboration between Etiometry, a US-based clinical decision-support software provider, and Terumo Cardiovascular, a US-based manufacturer of medical devices for cardiac and vascular surgery. This collaboration aims to provide advanced clinical decision support for adult cardiac surgery patients during and after their post-surgical recovery.
Major companies operating in the coronary artery bypass graft market are innovating and introducing new products, including a suite of medical devices, to gain a competitive advantage. For instance, CardioPrecision Ltd, a UK-based medical technology company, launched a suite of CoreVista devices designed for use in endoscopic vessel harvesting (EVH) during coronary artery bypass grafting (CABG) surgery. These devices aim to revolutionize EVH by offering a less invasive alternative to traditional open vessel harvesting, optimizing the environment for training and independent clinical practice.
In August 2022, Medtronic plc, a US-based medical device company, completed the acquisition of Affera Inc. for an undisclosed amount. This acquisition enhances Medtronic's cardiac ablation lineup by introducing a cardiac mapping and navigation platform, incorporating a distinctive diagnostic tool, focused pulsed field technology, and a radiofrequency ablation solution. Affera Inc. is a US-based medical technology company specializing in coronary artery bypass graft (CABG) procedures.
Major companies operating in the coronary artery bypass graft market report are MicroPort Scientific Corporation, CryoLife Inc., Johnson & Johnson Co, Abbott Laboratories, Medtronic plc, Stryker Corporation, Northwell Health, Boston Scientific Corporation, Penn Medicine, Geisinger Health System Co, Terumo Corporation, Edwards Lifesciences Corporation, Main Line Health Inc., Getinge AB, Teleflex Incorporated, W. L. Gore & Associates Inc., Guidant Group, LivaNova PLC, AtriCure Inc., Peter Surgical, Sorin Group, Cardiva Medical Inc., Genesee Biomedical Inc., Dextera Surgical Inc., Cardica Inc., Maquet Holding B.V. & Co.KG, Novadaq Technologies Inc., Karl Storz GmbH & Co. KG, Vitalitec International Medizintechnik GmbH, Hancock Jaffe Laboratories.
North America was the largest region in the coronary artery bypass graft market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary artery bypass graft market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coronary artery bypass graft market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The primary procedures for coronary artery bypass grafting include single coronary artery bypass graft (CABG) surgery, double coronary artery bypass graft (CABG) surgery, triple coronary artery bypass graft (CABG) surgery, quadruple coronary artery bypass graft (CABG) surgery, and others. Single coronary artery bypass graft (CABG) surgery is a surgical intervention utilized for the management of coronary heart disease. Both off-pump and on-pump methods are employed by various healthcare facilities, including hospitals, cardiology clinics, research institutes, and other end-users.
The coronary artery bypass graft research report is one of a series of new reports that provides coronary artery bypass graft market statistics, including the coronary artery bypass graft industry's global market size, regional shares, competitors with coronary artery bypass graft market share, detailed coronary artery bypass graft market segments, market trends and opportunities, and any further data you may need to thrive in the coronary artery bypass graft industry. This coronary artery bypass graft market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The coronary artery bypass graft market consists of revenues earned by entities by providing services such as bypass grafts, peripheral vascular grafts, hemodialysis access grafts, and endovascular stent grafts. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary artery bypass graft market also includes sales of forceps, vascular forceps, grasping forceps, needle holders, scissors, and clamps. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Coronary Artery Bypass Graft Market Characteristics3. Coronary Artery Bypass Graft Market Trends and Strategies32. Global Coronary Artery Bypass Graft Market Competitive Benchmarking33. Global Coronary Artery Bypass Graft Market Competitive Dashboard34. Key Mergers and Acquisitions in the Coronary Artery Bypass Graft Market
4. Coronary Artery Bypass Graft Market - Macro Economic Scenario
5. Global Coronary Artery Bypass Graft Market Size and Growth
6. Coronary Artery Bypass Graft Market Segmentation
7. Coronary Artery Bypass Graft Market Regional and Country Analysis
8. Asia-Pacific Coronary Artery Bypass Graft Market
9. China Coronary Artery Bypass Graft Market
10. India Coronary Artery Bypass Graft Market
11. Japan Coronary Artery Bypass Graft Market
12. Australia Coronary Artery Bypass Graft Market
13. Indonesia Coronary Artery Bypass Graft Market
14. South Korea Coronary Artery Bypass Graft Market
15. Western Europe Coronary Artery Bypass Graft Market
16. UK Coronary Artery Bypass Graft Market
17. Germany Coronary Artery Bypass Graft Market
18. France Coronary Artery Bypass Graft Market
19. Italy Coronary Artery Bypass Graft Market
20. Spain Coronary Artery Bypass Graft Market
21. Eastern Europe Coronary Artery Bypass Graft Market
22. Russia Coronary Artery Bypass Graft Market
23. North America Coronary Artery Bypass Graft Market
24. USA Coronary Artery Bypass Graft Market
25. Canada Coronary Artery Bypass Graft Market
26. South America Coronary Artery Bypass Graft Market
27. Brazil Coronary Artery Bypass Graft Market
28. Middle East Coronary Artery Bypass Graft Market
29. Africa Coronary Artery Bypass Graft Market
30. Coronary Artery Bypass Graft Market Competitive Landscape and Company Profiles
31. Coronary Artery Bypass Graft Market Other Major and Innovative Companies
35. Coronary Artery Bypass Graft Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Coronary Artery Bypass Graft Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on coronary artery bypass graft market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for coronary artery bypass graft? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Report Scope
Markets Covered:1) By Procedure: Single Coronary Artery Bypass Graft (CABG) Surgery; Double Coronary Artery Bypass Graft (CABG) Surgery; Triple Coronary Artery Bypass Graft (CABG) Surgery; Quadruple Coronary Artery Bypass Graft (CABG) Surgery; Other Procedures
2) By Method: Off-pump; On-pump
3) By End-Use: Hospitals; Cardiology Clinics; Research Institutes; Other End-Users
Key Companies Mentioned: MicroPort Scientific Corporation; CryoLife Inc.; Johnson & Johnson Co; Abbott Laboratories; Medtronic plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Delivery Format: PDF, Word and Excel Data Dashboard
Companies Mentioned
- MicroPort Scientific Corporation
- CryoLife Inc.
- Johnson & Johnson Co
- Abbott Laboratories
- Medtronic plc
- Stryker Corporation
- Northwell Health
- Boston Scientific Corporation
- Penn Medicine
- Geisinger Health System Co
- Terumo Corporation
- Edwards Lifesciences Corporation
- Main Line Health Inc.
- Getinge AB
- Teleflex Incorporated
- W. L. Gore & Associates Inc.
- Guidant Group
- LivaNova PLC
- AtriCure Inc.
- Peter Surgical
- Sorin Group
- Cardiva Medical Inc.
- Genesee Biomedical Inc.
- Dextera Surgical Inc.
- Cardica Inc.
- Maquet Holding B.V. & Co.KG
- Novadaq Technologies Inc.
- Karl Storz GmbH & Co. KG
- Vitalitec International Medizintechnik GmbH
- Hancock Jaffe Laboratories.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | February 2024 |
| Forecast Period | 2024 - 2028 |
| Estimated Market Value ( USD | $ 12.5 Billion |
| Forecasted Market Value ( USD | $ 17.37 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
